Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03981731
Other study ID # PROICM 2019-06 COH
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 14, 2020
Est. completion date January 14, 2022

Study information

Verified date September 2023
Source Institut du Cancer de Montpellier - Val d'Aurelle
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

the investigator proposes to use the cardiac coherence technique coupled with a hypnosis session to improve post-operative recovery.


Description:

The perioperative period is recognized as an anxiety-provoking period for patients. If for some patients, this anxiety is more or less manageable, for others, it is the major concern with regard to their intervention, fearing not to wake up, to remain in a coma. Consideration of this aspect is very important for patients who require surgery. It is also a concern for caregivers involved in the care of these patients, including anesthesiologists, surgeons and operating room staff. For many years, pharmacological premedication, including benzodiazepines, has been the gold standard in the treatment of preoperative anxiety. This systematic prescription is controversial in populations most exposed to side effects such as the elderly, patients with heart or respiratory diseases. Surgery also seems to influence the impact of premedication. For example, abdominal surgery and breast surgery are associated with a higher risk of agitation upon awakening. Mental preparation, based on simple explanations by the anaesthetist, is not enough to reduce patients' anxiety. A recent study evaluated the perioperative experience of patients receiving or not receiving premedication. It shows that benzodiazepines are associated with cognitive impairment and delayed extubation in the elderly. In addition, it seems to have little effect on patient anxiety when compared to a placebo. In this context of anxiety, an emotional regulation tool appears particularly relevant. Cardiac coherence" (CC) is a particular state of cardiac variability. This state is correlated with many physiological and psychological variables. It is possible to promote this state through different techniques. One of its practices, "fixed frequency guided breathing", seems relevant both in its principles and in its simplicity of implementation. This specific respiratory mode permits to rebalance the sympathetic - parasympathetic balance of the autonomic nervous system and reveals a state of calm vigilance. This simple, well-coded respiratory psychophysiological practice is widely used in many applications, such as for the most caricatural ones, the management of difficult situations where stress is a central element such as decision-making among fighter pilots on mission, in national education to improve academic learning (especially among anxious students) and also more generally in stress and anxiety management. This technique induces a refocusing of emotions by regulating the SNA and therefore a better regulation of the hormones involved in the emotional cascade. This practice has several advantages: - it is psychophysiological (psychocorporeal) and widely described in the scientific literature in several indications - it is completely free of charge and immediately accessible to the patient, regardless of time and place - it can be used at other anxiety-inducing times (e.g., imaging or biopsy tests) - it allows total patient autonomy, offering self-management of anxiety and independence from the presence of a third party - it can approach a hypnotic model by focusing and absorbing what it can induce on breathing, and thus share some of its benefits - It does not have any adverse effects. The major difficulty of this technique is the adherence and regularity of the practice. The optimal effect is dependent on regular training. To improve this adherence, an audio tape will be put online, read in a hypnotic tone, which will aim to explain respiratory physiology, the benefits of oxygenation on cells and metabolism; this will have the effect of understanding the interest and utility of this exercise and will contribute to induce a feeling of relaxation and well-being. This study will be a study of feasibility about a program based on the cardiac coherence technique in a context of perioperative anxiety.


Recruitment information / eligibility

Status Completed
Enrollment 53
Est. completion date January 14, 2022
Est. primary completion date January 14, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Age = 18 years old 2. Surgery for breast or gynaecological cancer requiring scheduled hospitalization for up to 3 days 3. Signing of informed consent before any specific procedure in the study 4. Patient affiliated to a social security system Exclusion Criteria: 1. Patients undergoing outpatient surgery for their cancer will not be included 2. Natural bradycardia (50 beats per minute) 3. Patient taking ß-blockers, digoxin, flecaine, isoptin, cordarone, diltiazem 4. Cardiac arrhythmias 5. Severe heart failure with ventricular ejection fraction < 40% 6. Uncontrolled chronic pain 7. Patients whose medical or psychological conditions do not allow them to complete the study or sign the consent 8. Patient does not understand the French language 9. Deaf and/or dumb patient 10. Adult patient under guardianship or curatorship

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cardiac coherence
An initiation session to cardiac coherence will take place between D-10 and D-7 before the operation (during the anaesthesia consultation) in order to obtain a breathing rate of 6 cycles/min via a free application (Respirelax) with listening to an audio tape. 3 cardiac coherence sessions per day of 5 min (before meals) during the 7 days preceding the operation. - The anaesthetic induction will be done with a session of cardiac coherence associated with listening to the audio tape.

Locations

Country Name City State
France Institut régional du cancer de Montpellier Montpellier Hérault

Sponsors (1)

Lead Sponsor Collaborator
Institut du Cancer de Montpellier - Val d'Aurelle

Country where clinical trial is conducted

France, 

References & Publications (6)

Agelink MW, Majewski TB, Andrich J, Mueck-Weymann M. Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam, and lorazepam. Crit Care Med. 2002 May;30(5):997-1006. doi: 10.1097/00003246-200205000-00008. — View Citation

Lepouse C, Lautner CA, Liu L, Gomis P, Leon A. Emergence delirium in adults in the post-anaesthesia care unit. Br J Anaesth. 2006 Jun;96(6):747-53. doi: 10.1093/bja/ael094. Epub 2006 May 2. — View Citation

McCraty R, Atkinson M, Tiller WA, Rein G, Watkins AD. The effects of emotions on short-term power spectrum analysis of heart rate variability. Am J Cardiol. 1995 Nov 15;76(14):1089-93. doi: 10.1016/s0002-9149(99)80309-9. Erratum In: Am J Cardiol 1996 Feb 1;77(4):330. — View Citation

Munoz HR, Dagnino JA, Rufs JA, Bugedo GJ. Benzodiazepine premedication causes hypoxemia during spinal anesthesia in geriatric patients. Reg Anesth. 1992 May-Jun;17(3):139-42. — View Citation

Pekcan M, Celebioglu B, Demir B, Saricaoglu F, Hascelik G, Yukselen MA, Basgul E, Aypar U. The effect of premedication on preoperative anxiety. Middle East J Anaesthesiol. 2005 Jun;18(2):421-33. — View Citation

Van den Bosch JE, Moons KG, Bonsel GJ, Kalkman CJ. Does measurement of preoperative anxiety have added value for predicting postoperative nausea and vomiting? Anesth Analg. 2005 May;100(5):1525-1532. doi: 10.1213/01.ANE.0000149325.20542.D4. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of patients who have enrolled in the pre-habilitation program A patient will be considered to have optimally adhered to the program if she performs at least 2/3 of the proposed cardiac coherence sessions (that represents 67% of the total number of sessions), that is, at least 14 sessions over the 7 days preceding the surgery. 7 days
Secondary The preoperative anxiety score by using the Amsterdam Preoperative Anxiety and Information Scale (APAIS) The anxiety scale consists of six items, each of which could be scored from 1 to 5 with the end poles "not at all" (1) and "extremely" (5). The score of the anxiety scale is the sum of these four questions, with a scoring range from 6 to 30. 7 days
Secondary Patient's satisfaction with perioperative period by using "Evaluation of the Vecu of General Anesthesia" questionnaire (EVAN-G) The validated EVAN-G questionnaire includes 26 questions whose results are grouped together to define 6 "dimensions": Attention Focus, Information, Privacy, Pain, Discomfort and Wait Times. From these scores, an overall satisfaction score is calculated (average of all scores). For each of the scores: the higher the score, the higher the satisfaction. For each dimension, scores were reduced on a scale from 0 to 100. The higher the score, the higher the perceived quality of the experience. The total score was the sum of the scores of the six dimensions reduced to 100. 48 hours
Secondary Measurement of the Postoperative Quality of Recovery (QoR) The quality of postoperative functional recovery will be assessed by the QoR-15 questionnaire, which assesses five dimensions of recovery (physical comfort ; emotional state ; physical independence ; physiological support ; and pain). Each item was rated on a ten-point Likert scale: none of the time, some of the time, usually, most of the time, and all the time. The total score on the QoR-15 ranges from 0 (poorest quality of recovery) to 150 (best quality of recovery). 10 days
Secondary Measurement of anxiety level by using a visual analogue scale It's a visual scale from 0 (no anxiety) to 100 (highest anxiety) 7 days
Secondary Measurement of wake-up quality by using a visual analogue scale It's a visual scale from 0 (best wake-up) to 100 (worst wake-up) 1 day
Secondary Measurement of post-operative pain by using a visual analogue scale It's a visual scale from 0 (no pain) to 100 (highest pain) 1 day
Secondary Measurement of post-operative fatigue by using a visual analogue scale It's a visual scale from 0 (no fatigue) to 100 (highest fatigue) 1 day
Secondary Measurement of comfort and satisfaction with care by using a visual analogue scale It's a visual scale from 0 (ideal care) to 100 worst care) 1 day
Secondary Number of patients taking anesthetic drugs at induction of anaesthesia 1 day
Secondary Number of patients taking anesthetic drugs during the post-interventional monitoring 1 day
Secondary Number of patients taking morphine in recovery room 1 day
Secondary Number of patients taking setrons (nausea and vomiting medication) 1 day
Secondary Rate of patients that consider continuing the program of cardiac coherence 1 day
Secondary Rate of patients willing to recommend the technique 1 day
Secondary Number of days of hospitalization 1 month
Secondary Number of patients taking morphine in peroperative 1 day
Secondary Measurement of pain at inclusion by using a visual analogue scale It's a visual scale from 0 (no pain) to 100 (highest pain) 1 day
Secondary The recruitment rate (proportion of patients consenting to participate in the study among eligible patients at the screening) and reasons for refusal. 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2